Because a majority of cancers originate in the epithelium, the development of a minimally invasive laser therapy endoscope is proposed for the treatment of early cancer and precancerous lesions. During treatment for bladder cancer, many early cancers go undiagnosed, resulting in the highest recurrence rate of any cancer. A new scanning fiber endoscope will be developed for integrated laser imaging, early tumor identification, staging, and treatment, using topically applied photosensitizer dyes. To provide accurate control of the laser treatment, the same micro-optical fiber scanner is used for both in vivo imaging and laser therapy. This dual functionality will insure pixel-accurate delivery of the high-intensity laser light. The fiber scanner is located at the distal tip of an ultrathin (1.2 mm outer diameter) and flexible endoscope. Initial testing will be conducted on living artificial tissue models and a rat bladder cancer model that have been seeded with cancer cells from culture. The resulting superficial tumors within the epithelium will be destroyed using fluorescence image-guided laser therapy at single pixel accuracy. Performance evaluations of two therapeutic laser wavelengths and optical cancer indicators will be used to choose the most effective system, taking into account efficiency and safety. All systems under testing will have a high performance versus low clinical cost in practice. Furthermore, there is broad application of this technology to earlier treatments among lung, colorectal, esophageal, pancreatic, and bile duct cancers. Due to the reduced length of this project there will be no development of an interactive computer interface that estimates dosimetry of the image-guided intervention under real-time feedback control for the purpose of minimizing collateral damage to the tissue.

Public Health Relevance

A new medical instrument and procedures for image-guided laser imaging, diagnosis, and treatment of bladder cancer will be developed using biomarkers approved for human use. The goal for the first two-years of this project will be to develop the instruments and to test proof-of concept effectiveness in a rat bladder cancer animal model. The eventual goal is to introduce to clinical practice a less-invasive, less costly, and more effective surveillance and treatment system for the management of patients at high risk for bladder cancer, which currently has the highest recurrence rate and highest cost of any other cancer in the USA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
1R01EB008119-01A1
Application #
7582486
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Zhang, Yantian
Project Start
2009-07-15
Project End
2011-06-30
Budget Start
2009-07-15
Budget End
2010-06-30
Support Year
1
Fiscal Year
2009
Total Cost
$445,443
Indirect Cost
Name
University of Washington
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Zhang, Liang; Kim, Amy S; Ridge, Jeremy S et al. (2013) Trimodal detection of early childhood caries using laser light scanning and fluorescence spectroscopy: clinical prototype. J Biomed Opt 18:111412
Zhang, Liang; Nelson, Leonard Y; Seibel, Eric J (2012) Spectrally enhanced imaging of occlusal surfaces and artificial shallow enamel erosions with a scanning fiber endoscope. J Biomed Opt 17:076019
Kundrat, Matthew J; Reinhall, Per G; Lee, Cameron M et al. (2011) High Performance Open Loop Control of Scanning with a Small Cylindrical Cantilever Beam. J Sound Vib 330:1762-1771
Lee, Cameron M; Engelbrecht, Christoph J; Soper, Timothy D et al. (2010) Scanning fiber endoscopy with highly flexible, 1 mm catheterscopes for wide-field, full-color imaging. J Biophotonics 3:385-407